<DOC>
	<DOC>NCT00858143</DOC>
	<brief_summary>This open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study was performed in order to examine the efficacy and safety of Somavert速 in treatment of subjects with acromegaly and its effects on acromegaly related co-morbidities.</brief_summary>
	<brief_title>Non Interventional Study For Patients Treated With Somavert速</brief_title>
	<detailed_description>Non probability samples</detailed_description>
	<mesh_term>Acromegaly</mesh_term>
	<criteria>Subjects with diagnosed acromegaly who were already being treated with Somavert速 or were to start treatment with Somavert速 were included in the study. Subjects treated with an investigational drug for treatment of acromegaly. Subjects with symptoms such visual field loss, cranial nerve palsies or intracranial hypertension, indicating need for surgery. Women who were pregnant or lactating.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study</keyword>
</DOC>